June 18, 2024 – Page 9 – Goldea Capital

CORRECTION — Apollo Senior Floating Rate Fund Inc. Declares June 2024 Monthly Distribution of $0.140 Per Share

Written by Customer Service on June 18, 2024. Posted in Public Companies.

In the news release, “Apollo Senior Floating Rate Fund Inc. Declares June 2024 Monthly Distribution of $0.140 Per Share,” issued 11-Jun-2024 by Apollo Senior Floating Rate Fund Inc. over GlobeNewswire, we are advised by the Fund that the third paragraph, first sentence reading “Ex-Date,” should read “June 21, 2024” rather than “June 20, 2024” as originally issued inadvertently. The complete, corrected release follows: NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) — (NYSE: AFT) – Apollo Senior Floating Rate Fund Inc. (the “Fund”) today announced the declaration of its distribution for the month of June 2024 of $0.140 per common share, payable on the date noted below. The following dates apply to the declared distribution: Ex-Date: June 21, 2024Record Date: June 21, 2024Payment Date: June 28, 2024Per Share Amount: $0.140 Apollo...

COMSovereign and Intelligent Waves Partner for Secure 5G, Drone Platforms and Software-as-a-Service Solutions Sales to the Government and DoD Markets

Written by Customer Service on June 18, 2024. Posted in Public Companies.

Solutions Partnership Adds Enhanced Sales, Integration and Management Services Capabilities for COMSovereign’s Full Portfolio of Hardware and Software Offerings TUCSON, AZ, June 18, 2024 (GLOBE NEWSWIRE) — COMSovereign Holding Corp. (OTC: COMS and COMSP) (“COMSovereign” or the “Company”), a U.S.-based developer of 4G LTE Advanced and 5G communication systems and solutions, today announced that it has added Intelligent Waves (IW) as a new solutions partner for its full array of hardware and software solutions and products as it seeks to expand its sales into the large Government and Department of Defense (DoD) markets. Intelligent Waves is a leading integrator that delivers mission-focused, multi-domain operational expertise and innovation to the Government through high-impact technology solutions in cybersecurity, data science,...

Reunion Gold Provides a Reminder Regarding Expiry of Warrants

Written by Customer Service on June 18, 2024. Posted in Public Companies.

LONGUEUIL, Québec, June 18, 2024 (GLOBE NEWSWIRE) — Reunion Gold Corporation (TSXV: RGD; OTCQX: RGDFF) (the “Company” or “Reunion Gold”) wishes to remind holders of outstanding common share purchase warrants issued on July 8, 2022 (the “Warrants”) that the Warrants will expire at 4:00 p.m. Vancouver time on Monday, July 8, 2024. As of June 14, 2024, there were 41,338,257 Warrants outstanding. Each whole Warrant entitles its holder to purchase one (1) common share of Reunion Gold at an exercise price of C$0.39 per share. Any Warrants not exercised prior to 4:00 p.m. Vancouver time on July 8, 2024 will expire and become void, and the holder will no longer be able to exercise such voided Warrants. There are 40,102,987 Warrants governed under the terms of the Warrant Indenture dated as of July 8, 2022 (the “Indenture”) by and among...

Powerdyne International Inc. Begins Preliminary Talks with an AI Motor Manufacturer for a Potential Acquisition or Merger

Written by Customer Service on June 18, 2024. Posted in Public Companies.

North Reading, MA, June 18, 2024 (GLOBE NEWSWIRE) — Powerdyne International, Inc. (Ticker: PWDY) announces the Company has begun preliminary talks with an AI motor manufacturer for a potential acquisition or merger. Powerdyne announced today that the Company has begun preliminary talks with an AI motor manufacturer about a potential acquisition or merger with Powerdyne. According to industry sources by 2025, AI-related sales will account for at least 20% of the $130 billion market and is expected to reach $156 billion by 2029 with an annual forecasted growth rate of 4%. The Company seeks to strategically position itself to capitalize on this demand. James O’Rourke said, “this potential acquisition or merger would greatly increase our top line and potentially open up new market opportunities in the rapidly growing Robotics and Artificial...

CORRECTION — Apollo Tactical Income Fund Inc. Declares June 2024 Monthly Distribution of $0.144 Per Share

Written by Customer Service on June 18, 2024. Posted in Public Companies.

In the news release, “Apollo Tactical Income Fund Inc. Declares June 2024 Monthly Distribution of $0.144 Per Share,” issued 11-Jun-2024 by Apollo Tactical Income Fund Inc. over GlobeNewswire, we are advised by the Fund that the third paragraph, first sentence reading “Ex-Date,” should read “June 21, 2024” rather than “June 20, 2024” as originally issued inadvertently. The complete, corrected release follows: NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) — (NYSE: AIF) – Apollo Tactical Income Fund Inc. (the “Fund”) today announced the declaration of its distribution for the month of June 2024 of $0.144 per common share, payable on the date noted below. The following dates apply to the declared distribution: Ex-Date: June 21, 2024Record Date: June 21, 2024Payment Date: June 28, 2024Per Share Amount: $0.144 Apollo Contact Information: Product...

Kaltura Takes Home Four Awards at Eventex 2024 Including Best Event Technology and Best Virtual Event Platform

Written by Customer Service on June 18, 2024. Posted in Public Companies.

For the second year in a row, Kaltura has won for every category in which it was nominated New York, NY, June 18, 2024 (GLOBE NEWSWIRE) — Kaltura (Nasdaq: KLTR), the Video Experience Cloud, has won four awards in this year’s 14th Global Eventex Awards. For the second year in a row, Kaltura’s solution took the top prize in every category in which it was nominated, demonstrating its continuing innovation in the field of webinars and virtual and hybrid events, most notably with its continued addition of AI-powered engagement and personalization tools. The awards for which Kaltura’s webinar and event platform is listed as a winner include: Best Event Technology Best Audience Engagement Technology Best Data Collection/Event Analytics Technology, and Best Virtual Event Platform Kaltura Events enables organizers to create, manage,...

GoHealth to Present at the Noble Capital Markets Consumer, Communications, Media, and Technology Emerging Growth Virtual Equity Conference

Written by Customer Service on June 18, 2024. Posted in Public Companies.

CHICAGO, June 18, 2024 (GLOBE NEWSWIRE) — GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced the company will present at the Noble Capital Markets Consumer, Communications, Media, and Technology Emerging Growth Virtual Equity Conference on Wednesday, June 26, 2024, at 2:00 p.m. Eastern Time. A live webcast of the presentation may be accessed through a link that will be posted on GoHealth’s Investor Relations website, https://investors.gohealth.com/. A replay will be available through the same link following the conference. About GoHealth, Inc. GoHealth is a leading health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers’ peace of mind when making healthcare decisions so they...

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

Written by Customer Service on June 18, 2024. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a fireside chat at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference on Tuesday, June 25, 2024, at 2:00 p.m. ET. A live webcast of the presentation will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conference. About CytomX TherapeuticsCytomX is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed...

Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection

Written by Customer Service on June 18, 2024. Posted in Public Companies.

– Phase 1b study will evaluate safety, pharmacokinetic and efficacy endpoints in participants with chronic hepatitis B virus infection with interim data expected by the end of 2024 – SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the first participant has been dosed in the Phase 1b trial of ABI-4334, a next-generation capsid assembly modulator (CAM) candidate in development for the treatment of chronic hepatitis B virus (HBV) infection. Chronic HBV (cHBV) infection is a leading cause of chronic liver disease and liver transplants globally, with the World Health Organization estimating that over one million people died in 2022 from HBV-related causes. Current...

CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec

Written by Customer Service on June 18, 2024. Posted in Public Companies.

– First Patient Dosed in Expanded Access Program and Enrollment Ongoing – IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that it has initiated an Expanded Access Program (EAP) for cretostimogene grenadenorepvec in the U.S. for patients with Non-Muscle Invasive Bladder Cancer (NMIBC) who are unresponsive to Bacillus Calmette-Guerin (BCG) and meet certain program eligibility criteria. The first patient has been dosed in the EAP and enrollment in the study is ongoing. “Bladder cancer is a highly recurrent disease with few treatment options available to patients,” said Ambaw Bellete, President &...

Day: June 18, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice